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Abstract 
Formal,  computer-interpretable  representations  of 
eligibility  criteria  would  allow  computers  to  better 
support key clinical research and care use cases such 
as  eligibility  determination.  To  inform  the 
development  of  such  formal  representations  for 
eligibility  criteria,  we  conducted  this  study  to 
characterize and quantify  the complexity present in 
1000  eligibility  criteria  randomly  selected  from 
studies  in  ClinicalTrials.gov.  We  classified  the 
criteria  by  their  complexity,  semantic  patterns, 
clinical  content,  and  data  sources.    Our  analyses 
revealed  significant  semantic  and  clinical  content 
variability.  We  found  that  93%  of  criteria  were 
comprehensible,  with  85%  of  these  criteria  having 
significant  semantic  complexity,  including  40% 
relying on temporal data. We also identified several 
domains of clinical content. Using the findings of the 
study  as  requirements  for  computer-interpretable 
representations  of  eligibility,  we  discuss  the 
challenges for creating such representations for use 
in clinical research and practice. 
Introduction and Background 
Clinical trials are one of the most valuable sources of 
evidence  on  the  efficacy  of  treatments  in  humans. 
Evidence  based  medicine  seeks  to  apply  findings 
from clinical trials to better evaluation and treatment 
in  clinical  populations  across  all  domains  of 
medicine. Aside from a JAMA study that examined 
the  prevalence  of  exclusion  criteria  in  excluding 
Women,  children,  the  elderly,  and  those  with 
common  medical  conditions  from  trials,  however, 
there has never been a formal study of the semantic 
and  syntactic  features  and  of  the  complexity  of 
eligibility  criteria
1.  What  is  needed  is  a  clear 
specification of the kinds of subjects studied in a trial, 
i.e., the clinical phenotype studied, to facilitate data 
pooling  and  the  application  of  pooled  and  study-
specific  results  to  individual  patients  or  to 
populations.   
While disease diagnosis (e.g. ICD-9) is often used as 
a stand-in for clinical phenotype, clinical phenotypes 
used in clinical studies are much more complex than 
can  be  captured  in  an  ICD  term.  The  phenotypes 
studied are often refined by their severity, associated 
complications,  or  response  to  specific  treatments 
(e.g.,  labile  Type  II  diabetes  requiring  insulin 
treatment). These complex phenotypes are explicitly 
stated in the eligibility criteria for the trial. In fact, the 
aggregate set of eligibility  criteria for any one trial 
defines  the  overall  clinical  phenotype  of  the 
population being studied in the trial. Each trial may 
have dozens of eligibility criteria, and each criterion 
may be extremely complex, in terms of both grammar 
and content. 
Several groups have created formal representations of 
eligibility criteria, which include CDISC’s ASPIRE
2, 
Arden  Syntax
3,  SAGE
4,  and  GELLO
5.    In  related 
work,  our  Trial  Bank  Project  team  at  UCSF  has 
developed  the  Eligibility  Rule  Grammar  and 
Ontology (ERGO) and its related formalism ERGO 
Annotation  to  standardize  complex  clinical 
phenotype  descriptions  as  “templates”  that,  when 
combined  with  terms  from  ontologies  and 
standardized vocabularies, can reproducibly describe 
phenotypes in a generic computable representation
6. 
The evaluation and development of eligibility criteria 
representations  would  be  greatly  assisted  by  an 
understanding of the types and range of clinical and 
semantic  features  commonly  seen  in  eligibility 
criteria. To our knowledge, however, there has never 
been  a  formal  study  of  the  semantic  and  syntactic 
features and the complexity of eligibility criteria. The 
goal  of  this  study  is  to  analyze  a  large  number  of 
randomly chosen eligibility criteria from actual trials 
across all clinical domains, to characterize the range 
and  types  of  complexities  present,  and  to  identify 
common semantic patterns. 
Materials and Methods 
On December 30, 2003, we downloaded all studies in 
ClinicalTrials.gov  as  a  collection  individual  XML 
files  (n=9117),  of  which  1000  were  randomly 
selected for this study. We extracted the text of these 
criteria, without any metadata (e.g., designations as 
“exclusion” or “inclusion” criteria, or clinical domain 
of  study)  because  we  were  analyzing  only  the 
semantic  and  clinical  content  in  the  criteria 
themselves (available in Supplementary Materials).  
We  imported  the  criteria  into  an  Excel  spreadsheet 
and analyzed them by hand (JR) for their content and 
46   
semantic structure. Initially we designated criteria as 
“comprehensible and selective” or “incomprehensible 
or  non-selective.”  We  designated  criteria  as 
“comprehensible  and  selective”  if  their  logic  was 
readily  apparent  and  effectively  defined  potential 
subjects  as  eligible  or  ineligible  for  the  study  (i.e., 
stated  an  allowed  or  disallowed  phenotype).  These 
criteria may have had minor grammatical or spelling 
errors that did not compromise the underlying logic, 
and are referred  to in  the remainder of this text  as 
Comprehensible  and  Selective  Eligibility 
Criteria(C&S  criteria).  We  designated  criteria  as 
“incomprehensible  or  non-selective”  if  they  were 
truncated or otherwise nonsensical, or if they did not 
define  a  phenotype  (e.g.,  the  statement  “History  of 
breast cancer allowed” does not describe a phenotype 
to  be  excluded  or  included  in  the  study  and  is 
therefore non-selective). We recorded the reasons that 
criteria  were  classified  as  “incomprehensible”  or 
“non-selective.” 
C&S criteria were then classified along several axes. 
First, they were designated as “simple” or “complex.”    
Simple  criteria  were  those  consisting  of  a  discrete 
clinical  concept  expressed  as  a  single  phrase  (e.g. 
lung cancer, anemia, uncontrolled hypertension) or its 
negation  (not  pregnant),  or  a  simple  quantitative 
comparison  (e.g.,  WBC  >  5000  cells/mm
3).  If  we 
were able to rewrite a criterion as a simple criterion 
by omitting a modifier or modifiers without changing 
the meaning of the criterion, it was counted as simple 
(e.g., “No uncorrected hypokalemia” was rewritten to 
“No  hypokalemia”,  the  simple  negation  of  a  noun 
phrase). All other criteria were deemed to be complex 
criteria. 
The second axis of classification for the criteria was 
by their high-level clinical content, i.e., whether the 
criterion concerned: 1) a clinical attribute of the study 
participant  (e.g.,  a  symptom,  a  disease),  2)  a 
treatment or intervention on the participant, or 3) a 
behavior  of  the  participant.  These  three  categories 
were defined after preliminary examination of criteria 
suggested  them  to  be  mutually  exclusive  and 
exhaustive in covering the high-level clinical content 
of all eligibility criteria. 
After classification of criteria by their complexity and 
their  high-level  clinical  content,  we  analyzed  the 
criteria for semantic and clinical patterns and tallied 
the  proportion  of  their  presence.  We  identified  and 
tallied the broad semantic patterns according to the 
following heuristics.  
1.  Boolean criteria include those with AND and OR 
connectors, or parentheses, commas, “/”, or other 
grammatical  proxies  for  AND  and  OR.  If  a 
“with”  could  be  converted  to  an  AND  without 
any loss of information (e.g., “Cirrhosis with a 
history  of  ascites”  was  rewritten  to  “Cirrhosis 
AND  a  history  of  ascites”),  the  criterion  was 
counted as ‘Boolean’. 
2.  Partially  specified  lists  were  treated  as  OR 
statements including each element of the list and 
therefore designated as  Boolean(e.g.“History of 
cardiac disease (e.g. MI, CHF))” was expanded 
to “History of cardiac disease OR MI OR CHF. 
3.  Phrases  with  connectors  “without”,  “except”, 
“unless”,  and  “other  than”  were  counted  as 
‘exclusion connectors’. 
4.  Criteria  with  semantic  connectors  commonly 
used  in  clinical  eligibility  criteria,  including  
“caused  by”,    “defined  by“,  and  “documented 
by”, “diagnosed by”, and “confirmed by” were 
tallied as ‘delimiting connectors’. 
5.  Phrases  were  counted  as  having  ‘temporal 
connectors’ if they contain temporal descriptors 
or comparators (e.g. “at least 3 times per week”), 
or references to temporal events during the study 
(e.g., “at hospital discharge”). 
6.  Criteria  that  could  be  rewritten  as  “if  then” 
statements were counted as ‘If then’ statements 
(e.g.,  “Prior  sentinel  node  biopsy  allowed 
provided nodes are pathologically negative” was 
rewritten to “If prior sentinel node biopsy then 
nodes are pathologically negative”). 
7.  C&S criteria were counted as ‘able to be reduced 
to simple criteria’ if they could be decomposed 
into  only  simple  statements  through  Boolean, 
if..then,  or  exclusion  decomposition(e.g.  No 
history of CHF and CAD can be broken down 
into the two simple rules: “No history of CHF” 
AND “No history of CAD”). 
Furthermore,  we  identified  patterns  of  clinical 
content and tallied the proportion of their presence:  
1.  Criteria pertaining to demographic data. 
2.  Criteria  that  refer  to  informed  consent  or  a 
participant’s  willingness  to  adhere  to  protocol 
requirements (e.g., return for follow up). 
3.  Criteria  pertaining  to  laboratory  and  other  test 
results  and  other  quantitative  data,  including 
stages,,  grades  or  other  standardized  clinical 
scales. Also included in this group were criteria 
containing  references  to  arithmetic  “normal 
values” (e.g. AST > 4 x Upper Limit of Normal). 
4.  Temporally  related  criteria.  These  included 
criteria  having  temporal  connectors  and 
comparators,  and  ranged  from  criteria  that 
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clearly  referred  to  an  attribute,  intervention  or 
behavior  that  was  present  at  the  “start  of  the 
study”, to criteria that refer to “within the past 6 
months”,  to  criteria  that  refer  to  “prior”  or 
“concurrent”  attributes,  interventions  or 
behaviors without any further specifications We 
distinguished  three  subtypes  of  temporally 
related criteria:  
a)  Well  specified  temporal  criteria  --  These 
criteria listed a clear time period with reference 
to a discrete date (e.g. study day 1, the day the 
patient received treatment). 
b)  Moderately  specified  temporal criteria  -- 
These criteria listed a clear time period, but with 
no reference to study dates (e.g., within the last 6 
months, within the prior 2 weeks), 
c)  Loosely  specified  temporal  criteria  --  These 
criteria  mainly  used  "prior"  or  "current"  as 
temporal specifiers. 
5.  Criteria that implicitly require clinical judgment, 
the details of which are not specified, but that the 
average  clinician  would  understand  and  find 
meaningful  (e.g., “eligible for statin therapy”). 
6.  Criteria  that  require  information  beyond  the 
criterion itself, e.g. from study meta-data or other 
criteria  (e.g.  “No  evidence  of  metastases” 
without  specifying  the  type  of  primary 
carcinoma).  
In addition to classifying our test criteria as above, 
we  also  reviewed  the  expressiveness  of  CDISC’s 
ASPIRE,  Arden  Syntax,  SAGE  and  GELLO  to 
represent  the  eligibility  criteria  patterns  detected  in 
this study. 
Results 
Criteria  were  first  divided  into  those  that  were 
comprehensible  (C&S  criteria)  and  those  that  were 
not  (Table  1).  The  vast  majority  of  criteria  (93%) 
were  C&S  criteria.  Table  1  also  describes  the 
proportion of criteria classified as incomprehensible 
due to three main reasons. 
Approximately 15% of the C&S criteria were either 
simple  statements  or  could  be  rewritten  as  such 
(Table 2). Many of these included negation or simple 
arithmetic  comparisons.  The  remaining  85%  of  the 
criteria were designated as “complex” and included a 
variety  of  semantic  patterns,  including  35%  with 
more than one type of the complex semantic patterns 
listed. However, 8% of these C&S criteria could be 
rewritten into two or more simple statements through 
Boolean, if..then, and exclusion decomposition.  
The  high-level  clinical  content  of  all  C&S 
criteria(Table 3)  referred to patient clinical attributes 
71%  of  the  time.  Criteria  specifying  treatments  or 
other interventions accounted for 27% of the criteria, 
and criteria referring to patient behavior occurred 2% 
of the time. Criteria containing at least two types of 
clinical content accounted for 7% of the total. 
 
 
Table 1.Comprehensibility of Randomly 
Selected Eligibility Criteria 
Total Eligibility Criteria  1000 (100%) 
Comprehensible Criteria (C&S 
criteria) 
932 (93.2 %) 
Incomprehensible Criteria  68(6.8%) 
Reasons Incomprehensible 
   1.Incomplete Statement 
   2.Doesn’t exclude subjects 
   3.Other 
  
 32/68 (47%) 
 31/68 (46%)     
   5/68 (7%) 
 
Table 2. Semantic Complexity and Variation in 
CSEC  (N = 932) 
Simple Criteria (SC)  
Proportion of CSEC  139/932 (15%) 
SC with negation  21/139 (15%) 
SC with arithmetic comparator  49/139 (35%) 
Complex Criteria (CC) 
Proportion of CSEC  793/932 (85%) 
CC  with  negation  205/793 (26%) 
CC with arithmetic comparator   113/793 (14%) 
CC with Boolean connector  423/793 (53%) 
CC with exclusion connector   25/793(3%) 
CC with defining connector   45/793 (6 %) 
CC with temporal connector  371/793 (47%) 
CC with if…then statement  80/793 (10%) 
CC with 2 or more of the above 
complex semantic patterns  
280/793 (35%) 
CC that can be reduced  to SC 
through decomposition 
64/793 (8%) 
 
Table 3. Clinical Content Variation 
1.C&S  criteria  specifying  patient 
clinical Attributes 
659/932(71%
) 
2.C&S  criteria  specifying 
treatments  or  interventions 
participant  has  received  or  will 
receive. 
314/932(34%
) 
3.C&S  criteria  specifying  patient 
behavior. 
35/932(4%) 
4. C&S criteria including at least 
2 of above 3 types of content. 
72/932(8%) 
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Table 4 shows detailed findings of clinical patterns in 
C & S criteria. Demographic criteria, including age 
and sex, were found in 2.5%,  and  3% pertained to  
informed  consent,  or  to  a  participant’s  willingness 
and  ability  to  participate  as  specified  in  the  study 
protocol. 
Approximately  23%  of  the  criteria  specified  the 
results  of  laboratory  tests,  other  studies,  and 
standardized  diagnostic  criteria,  which  ranged  from 
requiring  a  very  specific  numerical  value  for  a 
participant to meet the criteria of the study, to criteria 
that referred to “normal” values (e.g. “AST < Upper 
Limit of Normal”).  
Temporally related features were present in 40% of 
C&S  criteria.    In  approximately  1/3  of  these,  the 
timing  of  clinical  assessments,  interventions  or 
behaviors  were  well  to  moderately  well  defined  in 
relationship to the start of the study. In the remainder 
of  these  criteria,  timing  was  much  less  precisely 
specified (e.g., clinical  assessments or interventions 
“prior” to the study, or happening “concurrently”).  
Another  19%  of  criteria  depended  on  the  clinical 
judgment  of  a  clinician  (e.g.  “No  other  medical  or 
psychiatric  illness  that  would  preclude  study 
compliance”) without giving specific indications as to 
how  this  assessment  should  be  made.  Finally, 
approximately 24% of the criteria relied on details of 
the  particular  study  that  were  not  available  from 
analysis of the criterion by itself (e.g. “No evidence 
of  metastatic  disease”  without  an  indication  of  the 
primary cancer). 
Discussion 
Our  analysis  of  1000  eligibility  criteria  randomly 
drawn  from  ClinicalTrials.gov  demonstrates 
significant  semantic  and  clinical  variability  across 
criteria.  This  variability  presents  challenges  to 
informaticians, researchers, and clinicians.  The good 
news  for  informaticians  designing  expression 
languages  is  that  23%  of  C&S  criteria  are  simple 
criteria, or can be reduced to simple criteria through 
Boolean , exclusion, and if-then decomposition. On 
the other hand, 77% of C&S criteria remain complex 
to  evaluate  as  they  contain  one  or  more  of  the 
following  patterns:  9%  of  complex  criteria  involve 
the  use  of  semantic  connectors  which  are  not 
captured by the current representation languages or 
coded  data,  40%  require  the  definition  of  temporal 
constraints  (many  of  which  are  only  loosely 
specified), 19% require clinical judgment, and 24% 
require linkage to study metadata. Researchers trying 
to  determine  patient  eligibility  for  studies  face 
incomprehensible and ambiguous criteria as well as 
under-specified criteria requiring clinical judgment or 
assessments.  Furthermore,  7  %  of  criteria  require 
radiographic, histologic, or EKG data that may not be 
available in coded format in the EHR. Automation of 
screening based on these criteria may require natural 
language  processing  of  narrative  documents,  with 
attendant  problems  of  sensitivity  and  specificity. 
Clinicians  seeking  to  determine  if  a  study’s 
population is similar to their own patients are equally 
challenged to understand just what clinical phenotype 
was studied in a given trial. 
In  this  work,  we  conceptualize  the  clinical  domain 
referenced  in eligibility  criteria  to be orthogonal to 
the  criteria’s  form  (e.g.,  Boolean  combination)  and 
data sources (e.g., laboratory test results). We aimed 
to classify criteria in a manner that would be useful 
across  clinical  domains,  to  drive  development  of 
domain-independent  eligibility  criteria 
representations  that  will  allow  for  tools  and 
discoveries made in one domain to be applied to all 
areas  of  medicine,  including  facilitating  the 
automation  of  matching  potential  subjects  to  trials, 
designing  trials  to  expand  on  findings  from  prior 
Table 4.  Details of Clinical Content 
Variation in C&S criteria(N = 932) 
C&S criteria pertaining to Demographic 
Data       (N = 24/932,  2.5%) 
C&S criteria pertaining to Patient Abilities 
and Informed Consent (N = 28/932,  3%) 
C&S criteria with Labs, Studies, and 
Standardized Diagnostic Criteria (N = 
219/932, 23%) 
C&S criteria with Serum or Urine Lab 
tests 
7% 
C&S criteria with Radiographic Data  1% 
C&S criteria with other  lab tests(e.g. 
Echo, EKG, histology, vital signs) 
6% 
C&S  criteria  with  accepted  clinical 
diagnostic  criteria(e.g.  stages  and 
grades) 
5% 
C&S  criteria  with  labs  requiring 
clinical  interpretation(e.g. AST  > 4  X 
ULN) 
4% 
C&S criteria with Temporally Related 
Features  (N = 371/932, 40%) 
Well specified temporal C&S criteria  4% 
Moderately  specified  temporal  C&S 
criteria 
11% 
Loosely  specified  temporal  C&S 
criteria 
25% 
C&S criteria requiring Clinical Judgement              
(N = 174/932, 19%) 
C&S criteria dependent on Study Metadata              
(N = 221/932, 24%) 
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studies,  and  pooling  data  across  studies  for  meta-
analysis.  A  disease-specific  representation  format 
based on data elements and their values, such as that 
of the ASPIRE project, cannot satisfy the expressivity 
requirements  revealed  in  this  study.  Domain-
independent  languages  with  composition  capability, 
such  as  Arden  Syntax,  SAGE  and  GELLO,  do  not 
have this limitation. 
Additionally,  criteria  requiring  referencing  external 
sources,  and  those  based  on  ill-defined  criteria 
provide obstacles to the automation of clinical tasks 
across  medical  domains.  Such  criteria  have  to  be 
disambiguated, de-abstracted, and operationalized in 
terms  of  available  data.  Work  on  these  issues  will 
benefit  from  an  interdisciplinary  approach  in 
designing  ontologies  and  data  structures  that  allow 
access  not  only  to  current  sources  of  quantitative 
laboratory  data,  but  also  to  high-throughput  and 
imaging data that will one day be used regularly in 
clinical practice. 
One  strength  of  our  study  is  that  we  analyzed 
eligibility  criteria  without  restriction  to  clinical 
domain.  This method likely produced a wider range 
of variance  in criteria than  if we had restricted our 
analysis to specific domains, but is more reflective of 
the  true  range  of  complexity  in  eligibility  criteria. 
Researchers  in  a  specific  field  may  use  criterion 
patterns  that  are  not  used  in  other  fields,  but  we 
abstracted  common  semantic  patterns  and  our 
categories covered all patterns seen in our sample of 
1000 criteria.   
A limitation of this study is that all of the criteria we 
analyzed were taken from ClinicalTrials.gov, which 
may produce a bias towards criteria from the types of 
trials found in this database, e.g., more quantitative 
than qualitative. Other biases may include more well 
formed eligibility criteria because trials registered in 
ClinicalTrials.gov  may  be  of  higher  study  design 
quality  than  unregistered  trials.  Finally,  eligibility 
criteria  reported  to  ClinicalTrials.gov  may  be 
simplified  versions  of  more  detailed  eligibility 
criteria in actual study protocols.  Our categorization 
of complexity and clinical and semantic patterns will 
need  to  be  tested  against  criteria  extracted  directly 
from  study  protocols  to  demonstrate  its  full 
applicability. 
Given  the  diversity  of  these  criteria,  including 
incomprehensible and ill defined criteria, it may well 
be  advantageous  to  consider  the  formation  of  clear 
standards  for  clinical  researchers  to  follow  when 
writing  eligibility  criteria.  Our  work  provides  an 
initial  framework  for  considering  best  practices  for 
expressing  the  clinical  and  semantic  content  of 
criteria. While best practice criteria may be viewed as 
initially burdensome, we believe that the benefits of 
having more clearly written criteria will far outweigh 
the costs, and will facilitate formalization and optimal 
use  of  these  criteria  as  specific  phenotypes 
throughout  clinical  research  and  care  across  all 
domains of medicine.  
Conclusions and Future Directions 
There is significant variation in both the content and 
semantic  structure  of  eligibility  criteria  in  clinical 
trials.  Evaluations  of  how  current  formal 
representations handle the categories of clinical and 
semantic  patterns  we  have  documented  will  help 
move  the  field  forward.  We  believe  this 
characterization of eligibility criteria complexity will 
also  help  future  research  on  the  development  of 
formalized representations to capture criteria, as well 
as  the  automated  parsing  of  criteria  into  these 
formalized representations for computational support. 
Advances  in  generic  formal  representations  of 
eligibility criteria will provide the necessary semantic 
foundation for maximizing the ability of computers to 
help manage and apply complex clinical phenotypes 
as defined by eligibility criteria in clinical research.   
Supplementary Materials 
http://rctbank.ucsf.edu/home/ecanalysis.html. 
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